TGFB1 and neoplasm: Tumors associated with poor prognosis display significantly higher levels of phospho‐SMAD2/3 also in the tumor epithelium and activation of the TGFβ pathway has been linked to resistance to conventional and targeted chemotherapeutics (Huang et al, 2012; Brunen et al, 2013).